Skip to content

Drug interactions

Azelastine + Finerenone

Severity: Minor

Azelastine and Finerenone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Finerenone is cleared mainly by CYP3A4, and azelastine is reported as a weak CYP3A4 inhibitor, so finerenone exposure may increase slightly. Higher finerenone exposure raises the risk of hyperkalemia and reduced kidney function. Intranasal azelastine has low systemic exposure, so the effect is likely small.

What this interaction means in plain words

Azelastine and Finerenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Azelastine belongs to Respiratory; Finerenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4-mediated finerenone metabolism.

What to do

Monitor serum potassium and renal function when starting or changing either drug. Adjust finerenone dosing per labeling if potassium rises.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Azelastine and Finerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Azelastine with Finerenone?

MediHelp rates the interaction as minor. Azelastine and Finerenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Finerenone is cleared mainly by CYP3A4, and azelastine is reported as a weak CYP3A4 inhibitor, so finerenone exposure may increase slightly. Higher finerenone exposure raises the risk of hyperkalemia and reduced kidney function. Intranasal azelastine has low systemic exposure, so the effect is likely small.

How serious is the interaction between Azelastine and Finerenone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function when starting or changing either drug. Adjust finerenone dosing per labeling if potassium rises.

What other medicines interact with Azelastine?

MediHelp also lists interactions of Azelastine with, for example, Calcium / magnesium / potassium / sodium oxybates, Methadone, Sodium oxybate. The full list is on the Azelastine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in